Cellular senescence is considered a key biological program that can exert both protective and potentially pathogenic effects in tissues across the lifespan. If senescent cells persist, they are associated with chronic inflammation, disturbed tissue homeostasis and diverse disease phenotypes. In recent years, a clinically highly relevant field of research has emerged from this: Senotherapies – in particular senolytics (selective elimination of senescent cells) and senomorphics (modulation of senescence-associated signaling and secretion patterns) – are widely studied in preclinical models, while human evidence to date comes mainly from early, small studies or from indirect clinical data sets.
You May Also Like
- Restless legs syndrome in children
Relationship between restless legs syndrome and growing pains
- Between hope and evidence gaps
Tinnitus and phytotherapy
- Case Report
17-year-old patient with acne fulminans
- Oncology
Study updates from the ESMO Congress
- High-dose influenza vaccine
Lower hospitalization rates – even with heart failure
- From statins to metformin
Preventive pharmacology and longevity
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- From symptom to diagnosis